Qiaoyan Lian,Xiuling Song,Juhua Yang,Lulin Wang,Peihang Xu,Xiaohua Wang,Xin Xu,Bin Yang,Jianxing He,Chunrong Ju
Abstract:Increasing evidence revealed that lung microbiota dysbiosis was associated with pulmonary infection in lung transplant recipients (LTRs). Pneumocystis jirovecii ( P. jirovecii ) is an opportunistic fungal pathogen that frequently causes lethal pneumonia in LTRs. However, the lung microbiota in LTRs with P. jirovecii pneumonia (PJP) remains unknow.
What problem does this paper attempt to address?
The main issue this paper attempts to address is understanding the differences in lung microbiota among lung transplant recipients (LTRs) with Pneumocystis jirovecii pneumonia (PJP), Pneumocystis jirovecii colonization (PJC), and control groups. Specifically, the study aims to analyze the composition of microbiota in bronchoalveolar lavage fluid (BALF) samples from lung transplant recipients in different states using metagenomic next-generation sequencing (mNGS) and to explore the relationship between these microbiota changes and clinical variables.
### Main Research Questions:
1. **Differences in Lung Microbiota**: Investigate whether there are significant differences in lung microbiota among lung transplant recipients in PJP, PJC, and control groups.
2. **Microbiota Diversity**: Assess the diversity and richness of microbiota among PJP, PJC, and control groups.
3. **Relationship Between Microbiota and Clinical Variables**: Explore whether changes in lung microbiota are related to clinical variables such as age, renal function, nutritional status, and immune status.
### Research Methods:
- **Sample Collection**: Collected 72 BALF samples from 61 lung transplant recipients, including 20 PJP patients, 22 PJC patients, and 19 control group patients.
- **Sequencing Technology**: Used metagenomic next-generation sequencing (mNGS) to analyze the microbiota in BALF samples.
- **Data Analysis**: Evaluated microbiota diversity and composition differences using α diversity index, principal component analysis (PCA), and linear discriminant analysis effect size (LEfSe). Additionally, canonical correlation analysis (CCA) and Spearman correlation analysis were conducted to explore the relationship between microbiota and clinical variables.
### Main Findings:
- **Differences in Microbiota Composition**: The microbiota composition in the PJP group was significantly different from the other two groups, with lower species diversity in the PJP group.
- **Key Microbial Species**: The abundance of microbial species such as Pneumocystis jirovecii, Human gammaherpesvirus 4, Phreatobacter oligotrophus, and Pseudomonas balearica was significantly different in the PJP group.
- **Microbial Interactions**: P. jirovecii was negatively correlated with several other microbial species, indicating its presence may disrupt the ecological balance of lung microbiota.
- **Microbiota After Recovery**: The microbiota composition in the PJP recovery group was different from the PJP group but similar to the control group.
- **Correlation with Clinical Variables**: Clinical variables such as age, creatinine, total protein, albumin, IgG, neutrophils, lymphocytes, CD3+CD45+, CD3+CD4+, and CD3+CD8+ T cells were closely related to changes in lung microbiota.
### Conclusion:
This study reveals significant differences in lung microbiota among lung transplant recipients in PJP, PJC, and control groups, particularly the lower microbiota diversity in the PJP group. Additionally, the study finds that changes in lung microbiota are closely related to clinical variables such as age, renal function, nutritional status, and immune status. These findings contribute to a better understanding of the dynamics of lung microbiota in lung transplant recipients and their relationship with clinical outcomes.